MeVPMe11 (L), n=1 cell(s)

Main group: Visual Projection Neurons; Neurotransmitter consensus prediction: Glu

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - - - - 50.0 45.0 1.0 - - 96
1 - - - - - 399.0 436.0 - - - 835
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - 1.0 1
Pre - - - - - - 11.0 11
  AME
0 32
1 53
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 59
1 160

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses:96
Number of pre synapses:835
Number of output connections:2307
Coverage factor:1.0
Columnar completeness:0.26
Area completeness:0.61
Cell size (columns):236

Lobula

Number of post synapses:1
Number of pre synapses:11
Number of output connections:33
Coverage factor:1.0
Columnar completeness:0.00
Area completeness:0.00
Cell size (columns):4

Lobula Plate

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#MeVPMe11 (L) % % cumu.
0 aMe5 (R) ACh 24 24.0 17.1% 17.1%
1 MeVC20 (R) Glu 13 13.0 9.3% 26.4%
2 Tm5c (R) Glu 10 10.0 7.1% 33.6%
3 aMe6a (R) ACh 7 7.0 5.0% 38.6%
4 MeTu3c (R) ACh 5 5.0 3.6% 42.1%
5 Mi15 (R) ACh 5 5.0 3.6% 45.7%
6 Cm21 (R) GABA 4 4.0 2.9% 48.6%
7 MeTu1 (R) ACh 4 4.0 2.9% 51.4%
8 aMe22 (R) Glu 3 3.0 2.1% 53.6%
9 MeTu3b (R) ACh 3 3.0 2.1% 55.7%
10 MeVP14 (R) ACh 3 3.0 2.1% 57.9%
11 OA-AL2i3 (R) OA 3 3.0 2.1% 60.0%
12 OA-AL2i4 (R) OA 3 3.0 2.1% 62.1%
13 Cm25 (R) Glu 2 2.0 1.4% 63.6%
14 Cm35 (R) GABA 2 2.0 1.4% 65.0%
15 Cm4 (R) Glu 2 2.0 1.4% 66.4%
16 MeLo6 (R) ACh 2 2.0 1.4% 67.9%
17 MeVC27 (L) unclear 2 2.0 1.4% 69.3%
18 MeVC7a (L) ACh 2 2.0 1.4% 70.7%
19 MeVC9 (L) ACh 2 2.0 1.4% 72.1%
20 MeVP12 (R) ACh 2 2.0 1.4% 73.6%
21 MeVPMe3 (L) Glu 2 2.0 1.4% 75.0%
22 MeVPMe4 (L) Glu 2 2.0 1.4% 76.4%
23 aMe17b (R) GABA 1 1.0 0.7% 77.1%
24 aMe17e (R) Glu 1 1.0 0.7% 77.9%
25 aMe6c (R) Glu 1 1.0 0.7% 78.6%
26 aMe8 (R) ACh 1 1.0 0.7% 79.3%
27 Cm14 (R) GABA 1 1.0 0.7% 80.0%
28 Cm20 (R) GABA 1 1.0 0.7% 80.7%
29 Cm24 (R) Glu 1 1.0 0.7% 81.4%
30 Cm31a (R) GABA 1 1.0 0.7% 82.1%
31 Cm31b (R) GABA 1 1.0 0.7% 82.9%
32 Cm5 (R) GABA 1 1.0 0.7% 83.6%
33 Cm6 (R) GABA 1 1.0 0.7% 84.3%
34 Cm7 (R) Glu 1 1.0 0.7% 85.0%
35 Cm_unclear (R) ACh 1 1.0 0.7% 85.7%
36 Dm2 (R) ACh 1 1.0 0.7% 86.4%
37 l-LNv (R) unclear 1 1.0 0.7% 87.1%
38 LT58 (R) Glu 1 1.0 0.7% 87.9%
39 MeLo5 (R) ACh 1 1.0 0.7% 88.6%
40 MeLo9 (R) Glu 1 1.0 0.7% 89.3%
41 MeTu2a (R) ACh 1 1.0 0.7% 90.0%
42 MeVC10 (L) ACh 1 1.0 0.7% 90.7%
43 MeVC21 (R) Glu 1 1.0 0.7% 91.4%
44 MeVC6 (L) ACh 1 1.0 0.7% 92.1%
45 MeVP49 (R) unclear 1 1.0 0.7% 92.9%
46 MeVP6 (R) Glu 1 1.0 0.7% 93.6%
47 MeVP8 (R) ACh 1 1.0 0.7% 94.3%
48 MeVPaMe1 (R) ACh 1 1.0 0.7% 95.0%
49 MeVPLo2 (R) ACh 1 1.0 0.7% 95.7%
50 MeVPMe5 (L) Glu 1 1.0 0.7% 96.4%
51 MeVPMe6 (L) Glu 1 1.0 0.7% 97.1%
52 Mi10 (R) ACh 1 1.0 0.7% 97.9%
53 Mi18 (R) GABA 1 1.0 0.7% 98.6%
54 OLVC4 (L) unclear 1 1.0 0.7% 99.3%
55 TmY17 (R) ACh 1 1.0 0.7% 100.0%

Outputs

  instance NT total connections connections /#MeVPMe11 (L) % % cumu.
0 MeVP21 (R) ACh 212 212.0 8.2% 8.2%
1 Cm8 (R) GABA 182 182.0 7.0% 15.2%
2 MeVC20 (R) Glu 159 159.0 6.1% 21.3%
3 MeTu3b (R) ACh 112 112.0 4.3% 25.6%
4 MeVPaMe1 (R) ACh 110 110.0 4.2% 29.8%
5 aMe5 (R) ACh 107 107.0 4.1% 33.9%
6 Cm12 (R) GABA 97 97.0 3.7% 37.7%
7 MeVP7 (R) ACh 70 70.0 2.7% 40.3%
8 MeTu4d (R) ACh 63 63.0 2.4% 42.8%
9 MeTu3c (R) ACh 60 60.0 2.3% 45.1%
10 aMe9 (R) ACh 58 58.0 2.2% 47.3%
11 Cm17 (R) GABA 58 58.0 2.2% 49.5%
12 Tm5c (R) Glu 56 56.0 2.2% 51.7%
13 Pm8 (R) GABA 54 54.0 2.1% 53.8%
14 Cm7 (R) Glu 53 53.0 2.0% 55.8%
15 MeVPMe11 (R) Glu 52 52.0 2.0% 57.8%
16 MeLo5 (R) ACh 45 45.0 1.7% 59.5%
17 Cm20 (R) GABA 44 44.0 1.7% 61.2%
18 Cm24 (R) Glu 42 42.0 1.6% 62.8%
19 MeTu1 (R) ACh 42 42.0 1.6% 64.5%
20 Cm34 (R) Glu 38 38.0 1.5% 65.9%
21 aMe25 (R) unclear 37 37.0 1.4% 67.3%
22 Tm34 (R) Glu 34 34.0 1.3% 68.7%
23 Cm31b (R) GABA 31 31.0 1.2% 69.8%
24 MeVPMe2 (R) Glu 28 28.0 1.1% 70.9%
25 Cm10 (R) GABA 27 27.0 1.0% 72.0%
26 Cm3 (R) GABA 27 27.0 1.0% 73.0%
27 MeVP29 (R) ACh 26 26.0 1.0% 74.0%
28 MeVC23 (R) Glu 23 23.0 0.9% 74.9%
29 SLP249 (R) unclear 23 23.0 0.9% 75.8%
30 aMe30 (R) Glu 21 21.0 0.8% 76.6%
31 Cm13 (R) Glu 21 21.0 0.8% 77.4%
32 MeVC21 (R) Glu 21 21.0 0.8% 78.2%
33 aMe2 (R) Glu 20 20.0 0.8% 79.0%
34 MeVP40 (R) unclear 20 20.0 0.8% 79.7%
35 aMe8 (R) ACh 19 19.0 0.7% 80.5%
36 Pm12 (R) Glu 19 19.0 0.7% 81.2%
37 MeVC22 (R) Glu 17 17.0 0.7% 81.8%
38 MeVP43 (R) ACh 17 17.0 0.7% 82.5%
39 MeVP12 (R) ACh 16 16.0 0.6% 83.1%
40 Tm5a (R) ACh 16 16.0 0.6% 83.7%
41 TmY10 (R) ACh 15 15.0 0.6% 84.3%
42 SLP250 (R) unclear 14 14.0 0.5% 84.8%
43 Cm16 (R) Glu 12 12.0 0.5% 85.3%
44 MeVP24 (R) unclear 12 12.0 0.5% 85.8%
45 Tm5Y (R) ACh 12 12.0 0.5% 86.2%
46 aMe6c (R) Glu 11 11.0 0.4% 86.7%
47 MeVP59 (R) ACh 11 11.0 0.4% 87.1%
48 Mi18 (R) GABA 11 11.0 0.4% 87.5%
49 TmY21 (R) ACh 11 11.0 0.4% 87.9%
50 LT58 (R) Glu 10 10.0 0.4% 88.3%
51 MeVPaMe1 (L) ACh 10 10.0 0.4% 88.7%
52 MeVPaMe2 (R) Glu 10 10.0 0.4% 89.1%
53 LoVP53 (R) ACh 9 9.0 0.3% 89.4%
54 MeVP8 (R) ACh 9 9.0 0.3% 89.8%
55 MeVP42 (R) ACh 8 8.0 0.3% 90.1%
56 CL125 (R) unclear 7 7.0 0.3% 90.3%
57 Mi15 (R) ACh 7 7.0 0.3% 90.6%
58 Tm37 (R) Glu 7 7.0 0.3% 90.9%
59 Cm5 (R) GABA 6 6.0 0.2% 91.1%
60 Cm9 (R) Glu 6 6.0 0.2% 91.3%
61 MeLo6 (R) ACh 6 6.0 0.2% 91.6%
62 MeVP14 (R) ACh 6 6.0 0.2% 91.8%
63 aMe20 (R) unclear 5 5.0 0.2% 92.0%
64 aMe3 (R) Glu 5 5.0 0.2% 92.2%
65 Cm35 (R) GABA 5 5.0 0.2% 92.4%
66 Cm6 (R) GABA 5 5.0 0.2% 92.6%
67 Dm2 (R) ACh 5 5.0 0.2% 92.8%
68 LoVC19 (R) ACh 5 5.0 0.2% 93.0%
69 MeLo3b (R) ACh 5 5.0 0.2% 93.2%
70 MeTu4f (R) ACh 5 5.0 0.2% 93.3%
71 MeVPMe3 (R) Glu 5 5.0 0.2% 93.5%
72 Mi17 (R) GABA 5 5.0 0.2% 93.7%
73 Tm12 (R) ACh 5 5.0 0.2% 93.9%
74 5thsLNv_LNd6 (R) ACh 4 4.0 0.2% 94.1%
75 aMe17b (R) GABA 4 4.0 0.2% 94.2%
76 Cm30 (R) GABA 4 4.0 0.2% 94.4%
77 Cm_unclear (R) ACh 4 4.0 0.2% 94.5%
78 Tm30 (R) GABA 4 4.0 0.2% 94.7%
79 Tm33 (R) ACh 4 4.0 0.2% 94.8%
80 aMe10 (R) ACh 3 3.0 0.1% 95.0%
81 aMe17c (R) Glu 3 3.0 0.1% 95.1%
82 Cm11d (R) ACh 3 3.0 0.1% 95.2%
83 DNp27 (R) unclear 3 3.0 0.1% 95.3%
84 l-LNv (R) unclear 3 3.0 0.1% 95.4%
85 MeVC10 (L) ACh 3 3.0 0.1% 95.5%
86 MeVP30 (R) ACh 3 3.0 0.1% 95.7%
87 MeVPMe4 (L) Glu 3 3.0 0.1% 95.8%
88 MeVPMe5 (R) Glu 3 3.0 0.1% 95.9%
89 Pm13 (R) Glu 3 3.0 0.1% 96.0%
90 Tm16 (R) ACh 3 3.0 0.1% 96.1%
91 Tm26 (R) ACh 3 3.0 0.1% 96.2%
92 Tm38 (R) ACh 3 3.0 0.1% 96.3%
93 aMe_TBD1 (R) unclear 2 2.0 0.1% 96.4%
94 Cm14 (R) GABA 2 2.0 0.1% 96.5%
95 Cm23 (R) Glu 2 2.0 0.1% 96.6%
96 Cm25 (R) Glu 2 2.0 0.1% 96.7%
97 Cm27 (R) Glu 2 2.0 0.1% 96.7%
98 Cm28 (R) unclear 2 2.0 0.1% 96.8%
99 Cm32 (R) GABA 2 2.0 0.1% 96.9%
100 Cm4 (R) Glu 2 2.0 0.1% 97.0%
101 Lat2 (R) unclear 2 2.0 0.1% 97.0%
102 MeLo7 (R) ACh 2 2.0 0.1% 97.1%
103 MeVP2 (R) ACh 2 2.0 0.1% 97.2%
104 MeVP33 (R) ACh 2 2.0 0.1% 97.3%
105 MeVP36 (R) unclear 2 2.0 0.1% 97.3%
106 MeVP52 (R) ACh 2 2.0 0.1% 97.4%
107 MeVP55 (R) unclear 2 2.0 0.1% 97.5%
108 MeVP6 (R) Glu 2 2.0 0.1% 97.6%
109 MeVPMe2 (L) Glu 2 2.0 0.1% 97.7%
110 MeVPMe5 (L) Glu 2 2.0 0.1% 97.7%
111 Mi4 (R) GABA 2 2.0 0.1% 97.8%
112 PS272 (R) unclear 2 2.0 0.1% 97.9%
113 SMP217 (R) unclear 2 2.0 0.1% 98.0%
114 Tm9 (R) ACh 2 2.0 0.1% 98.0%
115 TmY13 (R) ACh 2 2.0 0.1% 98.1%
116 TmY17 (R) ACh 2 2.0 0.1% 98.2%
117 aMe22 (R) Glu 1 1.0 0.0% 98.2%
118 aMe26 (R) ACh 1 1.0 0.0% 98.3%
119 Cm1 (R) ACh 1 1.0 0.0% 98.3%
120 Cm15 (R) GABA 1 1.0 0.0% 98.3%
121 Cm19 (R) GABA 1 1.0 0.0% 98.4%
122 Cm2 (R) ACh 1 1.0 0.0% 98.4%
123 Cm21 (R) GABA 1 1.0 0.0% 98.5%
124 Dm8a (R) Glu 1 1.0 0.0% 98.5%
125 Lawf1 (R) ACh 1 1.0 0.0% 98.5%
126 Lawf2 (R) ACh 1 1.0 0.0% 98.6%
127 LC9 (R) ACh 1 1.0 0.0% 98.6%
128 LoVCLo3 (L) OA 1 1.0 0.0% 98.7%
129 LoVCLo3 (R) OA 1 1.0 0.0% 98.7%
130 LoVP100 (R) unclear 1 1.0 0.0% 98.7%
131 LoVP103 (R) unclear 1 1.0 0.0% 98.8%
132 LoVP12 (R) unclear 1 1.0 0.0% 98.8%
133 LoVP46 (R) Glu 1 1.0 0.0% 98.8%
134 LoVP96 (R) Glu 1 1.0 0.0% 98.9%
135 MeTu2a (R) ACh 1 1.0 0.0% 98.9%
136 MeTu4a (R) ACh 1 1.0 0.0% 99.0%
137 MeTu4c (R) ACh 1 1.0 0.0% 99.0%
138 MeVC24 (R) Glu 1 1.0 0.0% 99.0%
139 MeVP1 (R) ACh 1 1.0 0.0% 99.1%
140 MeVP15 (R) ACh 1 1.0 0.0% 99.1%
141 MeVP32 (R) ACh 1 1.0 0.0% 99.2%
142 MeVP35 (R) unclear 1 1.0 0.0% 99.2%
143 MeVP39 (R) unclear 1 1.0 0.0% 99.2%
144 MeVP54 (R) unclear 1 1.0 0.0% 99.3%
145 MeVP57 (R) unclear 1 1.0 0.0% 99.3%
146 MeVP63 (R) GABA 1 1.0 0.0% 99.3%
147 MeVP9 (R) ACh 1 1.0 0.0% 99.4%
148 MeVPMe10 (R) Glu 1 1.0 0.0% 99.4%
149 MeVPMe10 (L) Glu 1 1.0 0.0% 99.5%
150 MeVPMe7 (R) Glu 1 1.0 0.0% 99.5%
151 Mi9 (R) Glu 1 1.0 0.0% 99.5%
152 OA-AL2i3 (R) OA 1 1.0 0.0% 99.6%
153 OA-AL2i4 (R) OA 1 1.0 0.0% 99.6%
154 T2a (R) ACh 1 1.0 0.0% 99.7%
155 Tm20 (R) ACh 1 1.0 0.0% 99.7%
156 Tm29 (R) Glu 1 1.0 0.0% 99.7%
157 Tm35 (R) Glu 1 1.0 0.0% 99.8%
158 Tm36 (R) ACh 1 1.0 0.0% 99.8%
159 Tm39 (R) ACh 1 1.0 0.0% 99.8%
160 Tm4 (R) ACh 1 1.0 0.0% 99.9%
161 TmY14 (R) Glu 1 1.0 0.0% 99.9%
162 TmY19b (R) GABA 1 1.0 0.0% 100.0%
163 TmY5a (R) Glu 1 1.0 0.0% 100.0%